News

Fideres Consults On ANZ BBSW Benchmark Manipulation

Robert Chang November 10, 2017 No Comments

Fideres was retained by Australia’s financial markets regulator Australian Securities and Investments Commission (ASIC) to provide financial expertise and develop economic evidence to support allegations of benchmark manipulation within the [...]

Fideres’s Closet Indexers Research Mentioned In FT Article

Fideres February 13, 2017 No Comments

Fideres’s research on behalf of European NGO, Better Finance, has been mentioned in a Financial Times article. Fideres’s research replicates the European Securities and Markets Authority’s (ESMA) study into closet [...]

Fideres’s Generic Drugs Research Covered By Philadelphia Inquirer

Fideres January 10, 2017 No Comments

The Philadelphia Inquirer recently covered Fideres’s recent research on price increases of generic drugs as part of a full examination of the pharmaceutical industry. Alberto Thomas, founding partner at Fideres, [...]

Bloomberg Reports On Generic Drug Research By Fideres

Fideres December 22, 2016 No Comments

Fideres’s research on generic drug pricing was covered today by Bloomberg. The research analysed price increases for individual generic drugs among different manufacturers and the timings of these price increases. [...]

Fideres Mentioned In Bloomberg Article On Currency Derivatives

Fideres August 30, 2016 No Comments

Bloomberg published an article today about how mis-selling of currency derivatives are being exposed, especially in the aftermath of Brexit. Alberto Thomas, founding partner at Fideres, is quoted saying “We [...]

U.S. Class Action Alleges Conspiracy In The SSA Bond Market

Fideres May 19, 2016 No Comments

Labaton and Hausfeld have filed a class action in the U.S. alleging a conspiracy in the Supranational, Sub-sovereign and Agency bonds (SSA) market. Fideres’s analysis has been included in the [...]

U.S. Class Action Alleges Conspiracy In The SSA Bond Market

Fideres May 19, 2016 No Comments

Labaton and Hausfeld have filed a class action in the U.S. alleging a conspiracy in the Supranational, Sub-sovereign and Agency bonds (SSA) market. Fideres’s analysis has been included in the [...]

U.S. Class Action Alleges Conspiracy In The SSA Bond Market

Fideres May 19, 2016 No Comments

Labaton and Hausfeld have filed a class action in the U.S. alleging a conspiracy in the Supranational, Sub-sovereign and Agency bonds (SSA) market. Fideres’s analysis has been included in the [...]

Fideres Research On Corporate Bond Pricing Widely Reported

Fideres April 5, 2016 No Comments

Fideres research has been reported on by Bloomberg, Reuters and a number of other news organisations. The research found evidence of systemic under-pricing in the bond market, potentially costing bond [...]

U.S. Class Action Complaint Alleges IRS Fixing

Fideres November 26, 2015 No Comments

The latest class action complaint filed by Quinn Emanuel in the Southern District of New York on November 25, 2015 alleges that a group of dealer banks along with two [...]

Competition Economics Digital Markets Discrimination Financial Litigation Securities Litigation

London:  +44 20 3397 5160
New York:  +1 646 992 8510
Rome:  +39 06 8587 0405
Frankfurt:  +49 61 7491 63000
Johannesburg:  +27 11 568 9611
Madrid: +34 919 494 330

Legal Notice Privacy Policy